VETOQUINOL Corporate brochure 2007 (year 2006)

AN INTERNATIONAL GROUP Founded in the heart of the European drug market and close to Switzerland and Germany, Vétoquinol was quickly established overseas . Manufacturing and distribution subsidiary Distribution subsidiary Sales office Head office T here are two economic reasons for setting up overseas: • to obtain a return on expensive products, particularly in terms of research, over a wider area, • to gain access to the most buoyant markets in terms of the group’s sectors - companion animals such as dogs and cats versus livestock such as cattle and pigs. Geographically, the group covers the major world markets, and is well-established in more mature markets and also in fast-growing areas: Western Europe, North America and Asia. Firmly established in Europe, the group has opened up the North American market - ranked 3 rd in Canada and, more recently, the Asian market - China in 2005 and South Korea in 2006. In most countries, the sales networks are responsi- ble for different species and deal with specific market features in each market. VÉTOQUINOL’S INTERNATIONAL SUCCESS RELIES ON THE GROUP’S VALUES The main method of international expansion is by acquisition. Making the most of its partners’ expertise - an important selection criterion for Vétoquinol - the group’s policy is to retain existing teams. Vétoquinol grants them autonomy and permits use of whatever is needed in order to satisfy the particular economic and cultural characteristics of their individual market. Vétoquinol positions its workforce as closely as possible to its customers, both geographically and professionally. Vétoquinol will continue to expand internationally through further acquisitions, favouring collaboration with trade and industry and stepping up our presence in areas of high- consumption, particularly in Asia.